AU2002214081A1 - Listeria inocua, genome and applications - Google Patents
Listeria inocua, genome and applicationsInfo
- Publication number
- AU2002214081A1 AU2002214081A1 AU2002214081A AU1408102A AU2002214081A1 AU 2002214081 A1 AU2002214081 A1 AU 2002214081A1 AU 2002214081 A AU2002214081 A AU 2002214081A AU 1408102 A AU1408102 A AU 1408102A AU 2002214081 A1 AU2002214081 A1 AU 2002214081A1
- Authority
- AU
- Australia
- Prior art keywords
- genome
- applications
- listeria inocua
- inocua
- listeria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 241000186781 Listeria Species 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR00/12697 | 2000-10-04 | ||
| FR0012697A FR2814754B1 (fr) | 2000-10-04 | 2000-10-04 | Listeria innocua, genome et applications |
| PCT/FR2001/003061 WO2002028891A2 (fr) | 2000-10-04 | 2001-10-04 | Listeria innocua, genome et applications |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002214081A1 true AU2002214081A1 (en) | 2002-04-15 |
Family
ID=8855008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002214081A Abandoned AU2002214081A1 (en) | 2000-10-04 | 2001-10-04 | Listeria inocua, genome and applications |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20040018514A1 (fr) |
| EP (1) | EP1322763A2 (fr) |
| JP (1) | JP2004515227A (fr) |
| KR (1) | KR20030064404A (fr) |
| AU (1) | AU2002214081A1 (fr) |
| CA (1) | CA2424952A1 (fr) |
| FR (1) | FR2814754B1 (fr) |
| WO (1) | WO2002028891A2 (fr) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1328543B1 (fr) * | 2000-10-27 | 2009-08-12 | Novartis Vaccines and Diagnostics S.r.l. | Acides nucleiques et proteines derives des groupes de streptocoques a et b |
| AU2012200299B2 (en) * | 2000-10-27 | 2014-10-02 | J. Craig Venter Institute, Inc. | Nucleic acids and proteins from streptococcus groups A and B |
| US7368547B2 (en) * | 2003-02-03 | 2008-05-06 | Mississippi State University | Use of novel virulence-specific genes as targets for diagnosis and potential control of virulent strains of Listeria monocytogenes |
| US20060257894A1 (en) * | 2003-09-16 | 2006-11-16 | Michel Doumith | Molecular typing of listeria monocytogenes, hybridization supports and kits for said molecular typing |
| AU2005259732A1 (en) * | 2004-07-06 | 2006-01-12 | Warnex Research Inc. | Polynucleotides for the detection of Listeria species |
| WO2006028601A2 (fr) * | 2004-07-26 | 2006-03-16 | Nanosphere, Inc. | Technique permettant de distinguer un staphylocoque dore resistant a la methicilline d'un staphylocoque dore sensible a la methicilline dans une culture mixte |
| US7439022B2 (en) * | 2005-06-15 | 2008-10-21 | Kraft Foods Holdings, Inc. | Nucleic acids for detection of Listeria |
| US8206923B2 (en) * | 2006-04-24 | 2012-06-26 | Elvira Garza Gonzalez | Method for detection and multiple, simultaneous quantification of pathogens by means of real-time polymerase chain reaction |
| WO2009035954A1 (fr) * | 2007-09-12 | 2009-03-19 | 3M Innovative Properties Company | Procédés de détection de listeria monocytogenes |
| IE20080050A1 (en) * | 2008-01-24 | 2009-11-11 | Univ Cork | Listeria monocytogenes cytotoxin Listeriolysin S |
| EP2588628A1 (fr) | 2010-06-30 | 2013-05-08 | Life Technologies Corporation | Détection d'espèces listeria dans des échantillons alimentaires et environnementaux et procédés et compositions afférents |
| US20120052492A1 (en) * | 2010-08-30 | 2012-03-01 | Samsung Techwin Co., Ltd. | Oligonucleotides for detecting listeria spp. and use thereof |
| US20120052495A1 (en) * | 2010-08-30 | 2012-03-01 | Samsung Techwin Co., Ltd. | Oligonucleotides for detecting listeria monocytogenes and use thereof |
| US9422529B2 (en) | 2010-12-22 | 2016-08-23 | The Board Of Regents Of The University Of Texas System | Alphavirus compositions and methods of use |
| WO2012088473A1 (fr) | 2010-12-22 | 2012-06-28 | The Board Of Regents Of The University Of Texas System | Compositions à base d'alphavirus et leurs procédés d'utilisation |
| CN102676506A (zh) * | 2012-05-30 | 2012-09-19 | 曹际娟 | 单核细胞增生李斯特氏菌核酸标准样品、其建立方法及应用 |
| CN104017873B (zh) * | 2014-05-30 | 2017-05-10 | 浙江万里学院 | 用于同时检测海洋中五种致病菌以及三种毒力基因的多重pcr引物及其设计方法 |
| CN103981275A (zh) * | 2014-05-30 | 2014-08-13 | 浙江万里学院 | 用于同时检测海洋中四种致病菌的多重pcr引物及其设计方法 |
| ES2778727T3 (es) | 2014-08-25 | 2020-08-11 | Geneweave Biosciences Inc | Partículas de transducción no replicativas y sistemas indicadores basados en partículas de transducción |
| US11008602B2 (en) | 2017-12-20 | 2021-05-18 | Roche Molecular Systems, Inc. | Non-replicative transduction particles and transduction particle-based reporter systems |
| CN110511987B (zh) * | 2019-08-28 | 2023-07-18 | 华南理工大学 | 一种基于特异性基因靶标lmo1341的单增李斯特菌的PCR检测方法 |
| CN112725474B (zh) * | 2020-12-30 | 2022-05-20 | 广东省微生物研究所(广东省微生物分析检测中心) | 含有特异性分子靶标的单核细胞增生李斯特菌标准菌株及其检测和应用 |
| NL2036756B1 (en) * | 2024-01-05 | 2024-08-29 | Univ Shihezi | Fluorescent pcr method for detecting listeria monocytogenes and mycobacterium tuberculosis in milk |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5610012A (en) * | 1994-04-08 | 1997-03-11 | Wisconsin Alumni Research Foundation | DNA probes specific for virulent listeria monocytogenes |
| IT1288700B1 (it) * | 1996-04-30 | 1998-09-23 | Uni Degi Studi Di Udine | Metodica e relativi primer per l'identificazione di listeria monocytogenes in un substrato organico |
| CA2404988A1 (fr) * | 2000-04-11 | 2001-10-18 | Institut Pasteur | Genome de listeria monocytogenes, polypeptides et utilisations |
-
2000
- 2000-10-04 FR FR0012697A patent/FR2814754B1/fr not_active Expired - Fee Related
-
2001
- 2001-10-04 KR KR10-2003-7004886A patent/KR20030064404A/ko not_active Withdrawn
- 2001-10-04 CA CA002424952A patent/CA2424952A1/fr not_active Abandoned
- 2001-10-04 US US10/398,221 patent/US20040018514A1/en not_active Abandoned
- 2001-10-04 JP JP2002532473A patent/JP2004515227A/ja active Pending
- 2001-10-04 EP EP01982519A patent/EP1322763A2/fr not_active Ceased
- 2001-10-04 AU AU2002214081A patent/AU2002214081A1/en not_active Abandoned
- 2001-10-04 WO PCT/FR2001/003061 patent/WO2002028891A2/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004515227A (ja) | 2004-05-27 |
| KR20030064404A (ko) | 2003-07-31 |
| CA2424952A1 (fr) | 2002-04-11 |
| WO2002028891A2 (fr) | 2002-04-11 |
| FR2814754A1 (fr) | 2002-04-05 |
| FR2814754B1 (fr) | 2005-09-09 |
| EP1322763A2 (fr) | 2003-07-02 |
| US20040018514A1 (en) | 2004-01-29 |
| WO2002028891A3 (fr) | 2003-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002214081A1 (en) | Listeria inocua, genome and applications | |
| AU2001254857A1 (en) | Listeria monocytogenes genome, polypeptides and uses | |
| AU2002336367A1 (en) | Adamts13 genes and proteins and variants, and uses thereof | |
| AUPR459901A0 (en) | Instant messaging | |
| AU2002235128A1 (en) | Expression miniarrays and uses thereof | |
| AU2002254343A1 (en) | Halo-polymer nanocomposite compositions, methods, and products employing such compositions | |
| EP1247815A3 (fr) | Oligonucléotides modifiés et leurs utilisations | |
| AU2002221749A1 (en) | Synthetic viruses and uses thereof | |
| AU2002329873A1 (en) | Halogenated calixpyrroles, calixpyridinopyrroles and calixpyridines, and uses thereof | |
| AU2002211717A1 (en) | Stresscopins and their uses | |
| AU2001292936A1 (en) | Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines | |
| AU2002306709A1 (en) | Oncolytic rna replicons | |
| AU2001264852A1 (en) | Lactobacillusbeta -glucuronidase and dna encoding the same | |
| AU2001295185A1 (en) | Multiplexing-interleaving and demultiplexing-deinterleaving | |
| AU6594401A (en) | 6-heterocyclyl-3-oxo-3,4-dihydro-quinoxalines | |
| AU2001265096A1 (en) | Short-root gene, promoter, and uses thereof | |
| AU2001242625A1 (en) | Gene sequence | |
| IL153573A0 (en) | Clk-2, cek-7 and coq-4 genes, and uses thereof | |
| AU2001264247A1 (en) | GASC1 gene | |
| AU3883800A (en) | Hob-bp2h compositions, methods and uses thereof | |
| AUPR062500A0 (en) | Message processing | |
| AU2002220416A1 (en) | Oncolytic virus | |
| AU2001229463A1 (en) | Pathogen-reducing systems, compositions, articles and methods employing ozone | |
| AU2001266689A1 (en) | 4-benzyl-2-hydroxy-1,4-oxazin-3-one and polymorphic forms thereof | |
| AU2001285743A1 (en) | Adipose-related gene |